Navigation Links
Neuronal regulators offer potential targets for cancer
Date:3/19/2008

Boston, Mass. (March 19, 2008) -- Being too brainy can be a bad thing in a junior high cafeteria, where the social hierarchy favors other traits. "Braininess" also causes problems for cells. When a breast cell begins making the proteins normally produced in neurons, for example, it can acquire cancerous properties.

Now, researchers in Stephen Elledge's laboratory at Harvard Medical School (HMS) have identified some of the switches that control this transformation, providing promising new therapeutic targets in some types of cancer. Their results appear in the March 20 issue of Nature.

"These switches play an important physiologic role in neural development and pathologic role in cancer," says first author Thomas Westbrook, who is now an assistant professor at Baylor College of Medicine. "I'm optimistic that we can use small molecules to control them."

In a previous study, Westbrook showed that a protein called REST--which keeps neural programs silent in most parts of the body--serves as a tumor suppressor.

"He's now identified a protein that promotes tumor growth by tagging REST for destruction, thereby activating neural programs," says Elledge, who holds primary appointments in the HMS Department of Genetics and at Brigham and Women's Hospital.

If the protein REST worked at a club, he would be a bouncer, preventing dozens of rowdy patrons from causing trouble. REST serves as a "master repressor," keeping numerous neural genes silent in breast cells, lung cells, etc, where they could wreak havoc. When REST disappears, these genes roar to life, pushing cells to become more like neuron precursor cells.

But cells outside the nervous system keep neural genes silent for a reason. When neural genes get switched on in breast cells anchored to surfaces, for example, they acquire the ability to live without the anchoring that is essential for normal cells to survive. That is, they can grow in suspension, which is a
'/>"/>

Contact: Alyssa Kneller
public_affairs@hms.harvard.edu
617-432-0442
Harvard Medical School
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
2. Low level of neuronal receptor linked to mild cognitive impairment and Alzheimers disease
3. Deficient regulators in the immune system responsible for type 1 diabetes
4. Promising new TB drug given special status by US and European regulators
5. AARP Calls on State Regulators to Reject Proposed Settlement of TXU Buyout
6. Waters Offers U.S. Water Authorities Complimentary Drinking Water Testing for the Presence of Pharmaceuticals
7. Mirion Technologies to Showcase New Product Offerings for the Nuclear Industry During 10th Annual China International Nuclear Industry Exhibition
8. SearchMedica Offers Medical Professionals Six New Specialized Clinical Web Searches
9. Cardinal Health, GE Healthcare Broaden Relationship to Offer Greater Access to Myoview(TM) Imaging Agent
10. Peapod Offers First Ever Virtual Nutritionist
11. Agilysys Hosts IBM Specialist at Health Care Webinar Offering Data Storage Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int
(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
...e levels in men suffering from eating disorders. M...d more than women with the same problems, researc...with a weakening of the bones, which become danger...lead to osteoporosis, and an increased risk of fra...
... been funding researchers who have pioneered a new...r's blood supply directly. It represents a ne...lood vessels that feed a tumour, as well as activa... vessels to leak and break down. Due to restrictio...
...rmation inside a coronary stent is three times hig...majority of angioplasties involve placement of a s...tery to keep it open. But the very act of placing ...to prevent.// Till date, it has been thought...
...or that triggers blood vessel formation within the...Genentech Inc. and colleagues reported their disco...al growth factor, or EG-VEGF. The finding could le...pituitary and thyroid.// Scientists have know...
...e antioxidants, often as compounds known as flavon...contains higher levels of health-promoting flavono...k the action of harmful free radicals, which are p...scene for heart disease, cancer and other health p...
...to support immunity in elderly, frail and patients...ration, rate of infection is a common risk, especi...rchers at the University of Pittsburgh report on t...ak heart, over 70, or scheduled for mitral-valve p...
Other Medicine News:
(Date:12/4/2009)Opposes use of imported drugs often stored in tin cans and car trunks ,, WASHINGTON, Dec. 4 Today, the senior advocacy group RetireSafe urged the Senate to defeat the Dorgan Importation plan encomp
(Date:12/4/2009)MORRISTOWN, N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed
(Date:12/4/2009)RARITAN, N.J., Dec. 4 Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur
Breaking Medicine Technology:RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Stillbirth Not an Issue for Next Born 51358 1Stillbirth Not an Issue for Next Born 51358 2Researchers consider herd movements to help eradicate bovine TB 51355 1Researchers consider herd movements to help eradicate bovine TB 51355 2Texas Humane Legislation Network Calls for Puppy Mill Crackdown 51352 1Texas Humane Legislation Network Calls for Puppy Mill Crackdown 51352 2
...akland), Sponsored by AIDS Healthcare Foundation,(...thern California,HIV/AIDS Coalition (SCHAC) Could ...ong California Inmates, Governor Instructs Depart...ribution Program in California; AHF Notes Successf..., New York, Philadelphia and Washington,Already Sh...
...t Millions Who Suffer From Condition, NEW YORK, O... drug-eluting (dispensing), stents can benefit pat...(PAD) is taking place at,Montefiore Medical Center...,the study. Medicated, drug-coated stents have be...ars in treating coronary artery disease. PAD affe...
Other Medicine Technology:Veto of California's Condoms in Prisons Bill: "Politics Over Public Health," Says AHF 2Veto of California's Condoms in Prisons Bill: "Politics Over Public Health," Says AHF 3Peripheral Arterial Disease to be Treated With New Medicated Stent in Trial at Montefiore 2
Blunt electrode
J-Hook Electrode
... The 5mm AEM Laparoscopic Instruments incorporate ...uments are shielded and monitored to prevent stray...rument caused by insulation failure or capacitive ...he protective shield built into all AEM Instrument...
... The 5mm AEM Laparoscopic Instruments incorporate ...uments are shielded and monitored to prevent stray...rument caused by insulation failure or capacitive ...he protective shield built into all AEM Instrument...
Medicine Products: